1. Jiao WW, Mokrousov I, Sun GZ, Li M, Liu JW, Narvskaya O, et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J 2007; 120:814-9.
2. Chang B, Wu AW, Hansel NN, Diette GB. Quality of life in tuberculosis: a review of the English language literature. Qual Life Res 2004; 13 (10):1633-42.
3. Darvishpour Kakhki A, Masjedi MR. Factors Associated with Health-Related Quality of Life in Tuberculosis Patients Referred to the National Research Institute of Tuberculosis and Lung Disease in Tehran. Tuberc Respir Dis 2015; 78 (4):309-14.
4. Jagielski T, van Ingen J, Rastogi N, Dziadek J, Mazur PK, Bielecki J. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int 2014:Article ID. 645802.
5. Lenk S, Schroeder J. Genitourinary tuberculosis. Curr Opin Urol 2001; 11(1):93-8.
6. ZamanK. Tuberculosis: a global health problem. J Health Popul Nutr 2010; 28 (2):111-3.
7. Maher D CP, Spinaci S, Harries A. Treatment oftuberculosis: guidelines for national programmes, Geneva: World Health Organization. 2010; 1997.
8. Shahrezaei M, Maracy MR, Farid F. Factors Affecting Mortality and Treatment Completion of Tuberculosis Patients in Isfahan Province from 2006 to 2011. Int J Prev Med 2015; 6:91.
9. Fair E, Hopewell PC, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther 2007; 5(1):61-5.
11. Ganguly J, Ray S, Nandi S, Halder S, Kundu S, Mandal A. A study to evaluate pattern of rifampicin resistance in cases of sputum positive pulmonary tuberculosis. J of Evolution of Med and Dent Sci. 2015; 4:4762-8.
12. Fite E, Fenandez Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2016; 73:14-5.
13. Ardeleanue C, Andrei F, ceausa M, Ene D, Mihai M, Butur G, et al. Cellurar immune response in atypical tuberculosis diagnosed by PCR in paraffin embedded material. Rom J Morphol EmbryoL 2004; 45:63-72.
14. Purohit M, Mustafa T. Laboratory Diagnosis of Extra-pulmonary Tuberculosis (EPTB) in Resource-constrained Setting: State of the Art, Challenges and the Need. J Clin Diagn Res 2015; 9(4):EE01-6.
15. Chakravorty S, Sen MK, Tyagi JS. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol 2005 ; 43(9):4357-62.
16. Mikhailovich V, Lapa S, Gryadunov D, Sobolev A, Strizhkov B, Chernyh N, et al. Identification of Rifampin-Resistant Mycobacterium tuberculosis Strains by Hybridization, PCR, and Ligase Detection Reaction on Oligonucleotide Microchips. J Clin Microbiol 2001; 39(7):2531-2540.
17. Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ 1999; 160 (11):1597-603.
18. Ong A, Creasman J, Hopewell PC, Gonzalez LC, Wong M, Jasmer RM, et al.A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco.Clin Infect Dis 2004; 38 (1):25–31.
19. Gomes T, Reis-Santos B, Bertolde A, Johnson J L, Riley LW, Maciel EL. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis 2014; 14:9.
20. Rish JA, Eisenach KD, Cave MD, Reddy MV, Gangadharam PR, Bates JH. Polymerase chain reaction detection of Mycobacterium tuberculosis in formalinfixed tissue. Am J Respir Crit Care Med 1996; 153:1419–1423.
21. Li JY, Lo ST, Ng CS. Molecular detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Diagn Mol Pathol 2000; 9 (2):67–74.
22. Mazza-Stalder J, Nicod L, Janssens JP. Janssens, Extrapulmonary tuberculosis. Rev Mal Respir 2012; 29 (4):566-78.
23. Garcia-Rodriguez JF, Alvarez-Diaz H, Lorenzo-Garcia MV, Marino-Callejo A, Fernandez-Rial A, Sesma-Sanchez P. Extrapulmonary tuberculosis: epidemiology and risk factors, Enferm Infecc Microbiol Clin 2011; 29 (7):502-9.
24. Rafiee S, Sedaghat M, Anvari R, Hesam H, Nosrati H, Estiri A, et al. Smear positive pulmonary tuberculosis in Golestan province.18th National Congress on Tuberculosis, Sanandaj-Iran. 2007: 5.
25. Moarref M, Khasii K, Atashbar A. TB epidemiologic picture in Kermanshah at 2005.18th National Congress on Tuberculosis, Sanandaj-Iran. 2007; 82.
26. Arora VK, Gupra R. Trends of extrapulmonary tuberculosis under revised national tuberculosis control programme: A study from south Delhi, Indian. J Tuberc 2006; 53:77-83.
27. Secretariat of Health Surveillance. Epidemiological bulletin: special tuberculosis. Brasil: Secretariat of Health Surveillance. Portuguese, 2012 (Cited 1st November, 2014).Availablefrom: http://www.saude.rs.gov.br/upload/1337634001_TuberculoseBoletim%20Epidemio.pdf.
29. Solovic I, Jonsson J, Korzeniewska Kosela M, Chiotan DI, Pace-Asciak A, Slump E, et al. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. EuroSurveill2013; 18 (12):pii:20432.
30. Liefooghe R, Michiels N, Habib S, Moran MB, De Muynck A. Perception and social consequences of tuberculosis: a focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med 1995; 41(12):1685-92.
31. French CE, Antoine D, Gelb D, Jones JA, Gilbert RL, Watson JM Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis 2007; 11(5):577-84.
32. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49(9):1350-7.
33. Chander V, Raina S.K, Bhardwaj AK, Kashyap S, Gupta AK, Sood A. Clinico-epidemiological profile of extra pulmonary tuberculosis: a report from a high prevalence state of Northern India. Public Health Res 2012; 2(6):185-9.
34. Gunal S, Yang Z, Agarwal M, Koroglu M, Arici ZK, Durmaz R. Demographic and microbial characteristics of extrapulmonary tuberculosis cases diagnosed in Malatya, Turkey, 2001-2007. BMC Public Health 2011; 11:154.
35. Kulchavenya E, Zhukova I, Kholtobin D. Kholtobin, Spectrum of urogenital tuberculosis. J Infect Chemother 2013; 19(5):880-3.
36. Gurung R, Bhattacharya SK, Pradhan B, Gurung S, Singh YI. Phenotypic characterisation and drug sensitivity testing of mycobacteria isolated from extrapulmonary tuberculosis. 2010; 8(1):57–61.
37. Sachdeva R, Gadre DV, Talwar V.Characterization and drug susceptibility patterns of extrapulmonary mycobacterial isolates. Indian J Med Res 2002; 115:1025.
38. Lin JN, Lai CH, Chen YH, Lee SS, Tsai SS, Huang CK, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 2009;13(5):620-5.
39. Iseman M.D. A clinician’s guide to tuberculosis. Philadelphia, Lippincott Williams & Wilkins, 2001;22;322-323
1. Jiao WW, Mokrousov I, Sun GZ, Li M, Liu JW, Narvskaya O, et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J 2007; 120:814-9.
2. Chang B, Wu AW, Hansel NN, Diette GB. Quality of life in tuberculosis: a review of the English language literature. Qual Life Res 2004; 13 (10):1633-42.
3. Darvishpour Kakhki A, Masjedi MR. Factors Associated with Health-Related Quality of Life in Tuberculosis Patients Referred to the National Research Institute of Tuberculosis and Lung Disease in Tehran. Tuberc Respir Dis 2015; 78 (4):309-14.
4. Jagielski T, van Ingen J, Rastogi N, Dziadek J, Mazur PK, Bielecki J. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int 2014:Article ID. 645802.
5. Lenk S, Schroeder J. Genitourinary tuberculosis. Curr Opin Urol 2001; 11(1):93-8.
6. ZamanK. Tuberculosis: a global health problem. J Health Popul Nutr 2010; 28 (2):111-3.
7. Maher D CP, Spinaci S, Harries A. Treatment oftuberculosis: guidelines for national programmes, Geneva: World Health Organization. 2010; 1997.
8. Shahrezaei M, Maracy MR, Farid F. Factors Affecting Mortality and Treatment Completion of Tuberculosis Patients in Isfahan Province from 2006 to 2011. Int J Prev Med 2015; 6:91.
9. Fair E, Hopewell PC, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther 2007; 5(1):61-5.
11. Ganguly J, Ray S, Nandi S, Halder S, Kundu S, Mandal A. A study to evaluate pattern of rifampicin resistance in cases of sputum positive pulmonary tuberculosis. J of Evolution of Med and Dent Sci. 2015; 4:4762-8.
12. Fite E, Fenandez Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2016; 73:14-5.
13. Ardeleanue C, Andrei F, ceausa M, Ene D, Mihai M, Butur G, et al. Cellurar immune response in atypical tuberculosis diagnosed by PCR in paraffin embedded material. Rom J Morphol EmbryoL 2004; 45:63-72.
14. Purohit M, Mustafa T. Laboratory Diagnosis of Extra-pulmonary Tuberculosis (EPTB) in Resource-constrained Setting: State of the Art, Challenges and the Need. J Clin Diagn Res 2015; 9(4):EE01-6.
15. Chakravorty S, Sen MK, Tyagi JS. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol 2005 ; 43(9):4357-62.
16. Mikhailovich V, Lapa S, Gryadunov D, Sobolev A, Strizhkov B, Chernyh N, et al. Identification of Rifampin-Resistant Mycobacterium tuberculosis Strains by Hybridization, PCR, and Ligase Detection Reaction on Oligonucleotide Microchips. J Clin Microbiol 2001; 39(7):2531-2540.
17. Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ 1999; 160 (11):1597-603.
18. Ong A, Creasman J, Hopewell PC, Gonzalez LC, Wong M, Jasmer RM, et al.A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco.Clin Infect Dis 2004; 38 (1):25–31.
19. Gomes T, Reis-Santos B, Bertolde A, Johnson J L, Riley LW, Maciel EL. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis 2014; 14:9.
20. Rish JA, Eisenach KD, Cave MD, Reddy MV, Gangadharam PR, Bates JH. Polymerase chain reaction detection of Mycobacterium tuberculosis in formalinfixed tissue. Am J Respir Crit Care Med 1996; 153:1419–1423.
21. Li JY, Lo ST, Ng CS. Molecular detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Diagn Mol Pathol 2000; 9 (2):67–74.
22. Mazza-Stalder J, Nicod L, Janssens JP. Janssens, Extrapulmonary tuberculosis. Rev Mal Respir 2012; 29 (4):566-78.
23. Garcia-Rodriguez JF, Alvarez-Diaz H, Lorenzo-Garcia MV, Marino-Callejo A, Fernandez-Rial A, Sesma-Sanchez P. Extrapulmonary tuberculosis: epidemiology and risk factors, Enferm Infecc Microbiol Clin 2011; 29 (7):502-9.
24. Rafiee S, Sedaghat M, Anvari R, Hesam H, Nosrati H, Estiri A, et al. Smear positive pulmonary tuberculosis in Golestan province.18th National Congress on Tuberculosis, Sanandaj-Iran. 2007: 5.
25. Moarref M, Khasii K, Atashbar A. TB epidemiologic picture in Kermanshah at 2005.18th National Congress on Tuberculosis, Sanandaj-Iran. 2007; 82.
26. Arora VK, Gupra R. Trends of extrapulmonary tuberculosis under revised national tuberculosis control programme: A study from south Delhi, Indian. J Tuberc 2006; 53:77-83.
27. Secretariat of Health Surveillance. Epidemiological bulletin: special tuberculosis. Brasil: Secretariat of Health Surveillance. Portuguese, 2012 (Cited 1st November, 2014).Availablefrom: http://www.saude.rs.gov.br/upload/1337634001_TuberculoseBoletim%20Epidemio.pdf.
29. Solovic I, Jonsson J, Korzeniewska Kosela M, Chiotan DI, Pace-Asciak A, Slump E, et al. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. EuroSurveill2013; 18 (12):pii:20432.
30. Liefooghe R, Michiels N, Habib S, Moran MB, De Muynck A. Perception and social consequences of tuberculosis: a focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med 1995; 41(12):1685-92.
31. French CE, Antoine D, Gelb D, Jones JA, Gilbert RL, Watson JM Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis 2007; 11(5):577-84.
32. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49(9):1350-7.
33. Chander V, Raina S.K, Bhardwaj AK, Kashyap S, Gupta AK, Sood A. Clinico-epidemiological profile of extra pulmonary tuberculosis: a report from a high prevalence state of Northern India. Public Health Res 2012; 2(6):185-9.
34. Gunal S, Yang Z, Agarwal M, Koroglu M, Arici ZK, Durmaz R. Demographic and microbial characteristics of extrapulmonary tuberculosis cases diagnosed in Malatya, Turkey, 2001-2007. BMC Public Health 2011; 11:154.
35. Kulchavenya E, Zhukova I, Kholtobin D. Kholtobin, Spectrum of urogenital tuberculosis. J Infect Chemother 2013; 19(5):880-3.
36. Gurung R, Bhattacharya SK, Pradhan B, Gurung S, Singh YI. Phenotypic characterisation and drug sensitivity testing of mycobacteria isolated from extrapulmonary tuberculosis. 2010; 8(1):57–61.
37. Sachdeva R, Gadre DV, Talwar V.Characterization and drug susceptibility patterns of extrapulmonary mycobacterial isolates. Indian J Med Res 2002; 115:1025.
38. Lin JN, Lai CH, Chen YH, Lee SS, Tsai SS, Huang CK, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 2009;13(5):620-5.
Iseman M.D. A clinician’s guide to tuberculosis. Philadelphia, Lippincott Williams & Wilkins, 2001;22;322-323